Collaborate Disseminate
Giving psilocybin to rats made them more optimistic in the longer term, suggesting that the psychedelic substance could have great potential in treating a core symptom of depression in humans.Continue ReadingCategory: Body & MindTags: Psychedelic M… Continue reading Psilocybin reveals another mental health benefit
After comparing the long-term effects of the psychedelic psilocybin and a commonly prescribed antidepressant, new research found that both significantly reduced depression. However, psilocybin provided something more: a significant boost to quality of … Continue reading Psilocybin equal to SSRI for depression, but better for overall well-being
We were this close to seeing Ecstasy being incorporated into therapy in the US in 2024. Now, we have to wait either a little or a lot – depending on how the chips fall. Let’s have a closer look at where we’re currently at.Continue ReadingCategory: Medi… Continue reading US FDA refuses to approve MDMA for PTSD therapy – now what?
We were this close to seeing Ecstasy being incorporated into therapy in the US in 2024. Now, we have to wait either a little or a lot – depending on how the chips fall. Let’s have a closer look at where we’re currently at.Continue ReadingCategory: Medi… Continue reading US FDA refuses to approve MDMA for PTSD therapy – now what?
Two new species of hallucinogenic fungi have been identified and officially described, joining the ranks of around 140 known types of these psychoactive gilled mushroom.Continue ReadingCategory: Biology, ScienceTags: Stellenbosch University, South Afri… Continue reading Two new hallucinogenic mushroom species discovered by fungi fans
Psilocybin mushrooms have been illegal since the ’70s. Deemed not to be beneficial to health and considered ripe for abuse, it’s only relatively recently that research highlighting the medicinal benefits of psilocybin, particularly in treating psychiat… Continue reading Fast, reliable test measures potency of psilocybin mushrooms
An effective single-dose, long-term treatment for anxiety could be within reach, with the phase 2b clinical trial of MM-120 reported to have passed the stage with flying colors. The makers, MindMed, now plan to hold an end-of-phase meeting with the US … Continue reading Single-dose drug to quash anxiety passes another trial milestone
Results from a recent clinical trial have demonstrated that psilocybin-assisted therapy is effective at treating moderate-to-severe depression in patients with curable and incurable cancer. In a first, the drug was given to small groups of patients sim… Continue reading Psilocybin effectively treats depression in cancer patients, study finds
A new study into using ketamine to treat depression has yielded surprising results. Despite the unique way in which the researchers ensured the trial was ‘blind’, those who received a placebo had the same improvement in symptom severity as those admini… Continue reading Blind ketamine study yields surprising placebo effect
Researchers have found that treating Special Operations Forces veterans with two psychedelics improved their mental health symptoms and, unexpectedly, their cognitive functioning. The findings underscore the benefits of psychedelic therapy, especially … Continue reading Psychedelics improve mental health & cognition in Special Ops vets